Boulter JM - Search Results

1

TCR affinity and negative regulation limit autoimmunity.

Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B, Gallimore A, Gascoigne NR, Ohashi PS. Gronski MA, et al. Among authors: boulter jm. Nat Med. 2004 Nov;10(11):1234-9. doi: 10.1038/nm1114. Epub 2004 Oct 3. Nat Med. 2004. PMID: 15467726 Free article.

2

Potent T cell agonism mediated by a very rapid TCR/pMHC interaction.

Boulter JM, Schmitz N, Sewell AK, Godkin AJ, Bachmann MF, Gallimore AM. Boulter JM, et al. Eur J Immunol. 2007 Mar;37(3):798-806. doi: 10.1002/eji.200636743. Eur J Immunol. 2007. PMID: 17295390 Free PMC article.

3

Antagonism of cytotoxic T-lymphocyte activation by soluble CD8.

Sewell AK, Gerth UC, Price DA, Purbhoo MA, Boulter JM, Gao GF, Bell JI, Phillips RE, Jakobsen BK. Sewell AK, et al. Among authors: boulter jm. Nat Med. 1999 Apr;5(4):399-404. doi: 10.1038/7398. Nat Med. 1999. PMID: 10202928

4

Structural and kinetic basis for heightened immunogenicity of T cell vaccines.

Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V. Chen JL, et al. Among authors: boulter jm. J Exp Med. 2005 Apr 18;201(8):1243-55. doi: 10.1084/jem.20042323. J Exp Med. 2005. PMID: 15837811 Free PMC article.

5

Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.

Boulter JM, Jakobsen BK. Boulter JM, et al. Clin Exp Immunol. 2005 Dec;142(3):454-60. doi: 10.1111/j.1365-2249.2005.02929.x. Clin Exp Immunol. 2005. PMID: 16297157 Free PMC article. Review.

6

Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.

Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, Milicic A, Price DA, Sewell AK. Laugel B, et al. J Biol Chem. 2007 Aug 17;282(33):23799-810. doi: 10.1074/jbc.M700976200. Epub 2007 May 31. J Biol Chem. 2007. PMID: 17540778 Free article.

7

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Wooldridge L, Lissina A, Vernazza J, Gostick E, Laugel B, Hutchinson SL, Mirza F, Dunbar PR, Boulter JM, Glick M, Cerundolo V, van den Berg HA, Price DA, Sewell AK. Wooldridge L, et al. Among authors: boulter jm. Eur J Immunol. 2007 May;37(5):1323-33. doi: 10.1002/eji.200636765. Eur J Immunol. 2007. PMID: 17429845 Free PMC article.

8

Functional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptor.

Gostick E, Cole DK, Hutchinson SL, Wooldridge L, Tafuro S, Laugel B, Lissina A, Oxenius A, Boulter JM, Price DA, Sewell AK. Gostick E, et al. Among authors: boulter jm. Eur J Immunol. 2007 Feb;37(2):479-86. doi: 10.1002/eji.200636243. Eur J Immunol. 2007. PMID: 17273992 Free PMC article.

9

T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.

Cole DK, Dunn SM, Sami M, Boulter JM, Jakobsen BK, Sewell AK. Cole DK, et al. Among authors: boulter jm. Mol Immunol. 2008 May;45(9):2700-9. doi: 10.1016/j.molimm.2007.12.009. Epub 2008 Feb 19. Mol Immunol. 2008. PMID: 18243322

10

Human TCR-binding affinity is governed by MHC class restriction.

Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E, Price DA, Gao GF, Sewell AK, Jakobsen BK. Cole DK, et al. Among authors: boulter jm. J Immunol. 2007 May 1;178(9):5727-34. doi: 10.4049/jimmunol.178.9.5727. J Immunol. 2007. PMID: 17442956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters